ProfileGDS4718 / 219024_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 88% 89% 90% 84% 84% 82% 89% 87% 88% 86% 88% 87% 87% 79% 82% 87% 86% 89% 84% 88% 89% 88% 88% 84% 83% 86% 86% 87% 85% 85% 85% 91% 89% 82% 88% 91% 86% 88% 90% 88% 84% 85% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4735785
GSM549102patient 115, normal, homogenized [OPG study]8.7831588
GSM549104patient 119, normal, homogenized [OPG study]9.1237989
GSM549108patient 138, normal, homogenized [OPG study]9.1211990
GSM549119patient 077, normal, homogenized [OPG study]8.338684
GSM549133patient 032, cancer, homogenized [OPG study]8.4399584
GSM549139patient 042, cancer, homogenized [OPG study]8.1331182
GSM549099patient 107, normal, homogenized [OPG study]8.9608189
GSM549109patient 139, normal, homogenized [OPG study]8.7678187
GSM549110patient 046, normal, homogenized [OPG study]8.8844888
GSM549114patient 063, normal, homogenized [OPG study]8.6559386
GSM549122patient 082, normal, homogenized [OPG study]8.8962288
GSM549134patient 033, cancer, homogenized [OPG study]8.7490287
GSM549136patient 036, cancer, homogenized [OPG study]8.8563487
GSM549140patient 044, cancer, homogenized [OPG study]7.8210479
GSM549111patient 047, normal, homogenized [OPG study]8.1477982
GSM549113patient 057, normal, homogenized [OPG study]8.9117587
GSM549132patient 031, cancer, homogenized [OPG study]8.6049886
GSM549137patient 038, cancer, homogenized [OPG study]8.9469289
GSM549142patient 047, cancer, homogenized [OPG study]7.9692784
GSM549100patient 110, normal, homogenized [OPG study]8.9058788
GSM549107patient 135, normal, homogenized [OPG study]9.0618589
GSM549115patient 068, normal, homogenized [OPG study]9.0992988
GSM549116patient 072, normal, homogenized [OPG study]8.9901288
GSM549120patient 078, normal, homogenized [OPG study]8.3292284
GSM549131patient 030, cancer, homogenized [OPG study]8.3200383
GSM549118patient 074, normal, homogenized [OPG study]8.6639486
GSM549129patient 027, cancer, homogenized [OPG study]8.550186
GSM549123patient 088, normal, homogenized [OPG study]8.7232887
GSM549124patient 006, cancer, homogenized [OPG study]8.4042785
GSM549126patient 015, cancer, homogenized [OPG study]8.4584685
GSM549128patient 025, cancer, homogenized [OPG study]8.5340485
GSM549103patient 117, normal, homogenized [OPG study]9.2689291
GSM549117patient 073, normal, homogenized [OPG study]9.1731889
GSM549138patient 041, cancer, homogenized [OPG study]8.0683282
GSM549141patient 045, cancer, homogenized [OPG study]8.965688
GSM549130patient 028, cancer, homogenized [OPG study]9.2928691
GSM549101patient 111, normal, homogenized [OPG study]8.5688586
GSM549105patient 128, normal, homogenized [OPG study]8.8057388
GSM549106patient 134, normal, homogenized [OPG study]9.3206890
GSM549112patient 048, normal, homogenized [OPG study]8.8843288
GSM549125patient 011, cancer, homogenized [OPG study]8.3251484
GSM549127patient 024, cancer, homogenized [OPG study]8.5009785
GSM549135patient 035, cancer, homogenized [OPG study]8.737186